Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

Journal of Urban Health

Volumn 77, Issue 3, 2000, Pages 331-345

  Thiede, Hanne ^a,b   Hagan, Holly ^a,b   Murrill, Christopher S ^a  

^a Public Health Seattle King County   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HBV; HCV; HIV; Injection Drug Use; Methadone Treatment; Prevention

Indexed keywords

METHADONE;

ADULT; ARTICLE; DRUG USE; FEMALE; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; METHADONE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; WASHINGTON;

EID: 0033841367     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02386744     Document Type: Article

References (29)

1. HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic
2. Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996
3. Incidence of bloodborne viral infections and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995
4. Injecting risk behaviors among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs
5. Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995
6. Long-term trends in self-reported HIV risk behavior: Injection drug users in Los Angeles, 1987 through 1995
7. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993
8. Incidence rate and risk factors for HCV seroconversion among injection drug users in an area with low HIV seroprevalence
9. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study
10. Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men
11. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin
12. Sex, drugs and HIV counseling and testing: A prospective study of behavior-change among methadone-maintenance clients in New England
13. Methadone maintenance and the likelihood of risky needle-sharing
14. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
15. HIV risk-taking behaviour among injection drug users currently, previously and never enrolled in methadone treatment
16. Longitudinal sexual behavior changes in injecting drug users
17. Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City
18. HIV seroconversion in intravenous drug users in San Francisco, 1985-1990
19. Drug abuse treatment as AIDS prevention
20. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: Factors influencing hepatitis C serostatus
21. Methadone maintenance and hepatitis C virus infection among injecting drug users
22. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial
23. Sharing of drug preparation equipment as a risk factor for hepatitis C virus incidence
24. Effective medical treatment of opiate addiction
25. Methadone maintenance versus 180-day psychosocially enriched detoxification for treatment of opioid dependence
26. Active heroin injectors' perceptions and use of methadone maintenance: Cynical performance or self-prescribed risk reduction?
27. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996